Fewer eye jabs for vision loss? study tests simpler injection schedule
NCT ID NCT06742307
Summary
This study is testing if a simpler, fixed schedule of faricimab eye injections given every 3-4 months can successfully maintain vision in people with wet age-related macular degeneration (AMD) after initial treatment. It aims to see if this less frequent schedule works as well as more intensive ones, which could reduce the burden of frequent clinic visits and injections. The study will follow 40 participants for one year to monitor their vision and eye health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION CHOROIDAL NEOVASCULARIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Ophthalmology, United Chrisitian Hospital
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.